BioSpace News Archive

Pharm Country

MindMed Launches Project Lucy Focused on LSD Experiential Therapy For Anxiety Disorders

Targeting a Phase 2b psychedelic assisted therapy trial for the treatment of anxiety disorders

June 4, 2020
·
5 min read
Deals

Alpha Tau Medical Announces Successful Completion of New $26 Million Funding Round

Alpha Tau Medical, the developer of breakthrough alpha-radiation cancer therapy Alpha DaRT, is pleased to announce the closing of a Series B equity financing of $26 million.

June 4, 2020
·
2 min read
Lumenis MOSES Technology Wins 2020 MedTech Breakthrough Award for Innovation in Surgical Technology

Annual Awards Program Honors Outstanding Health & Medical Technology Products and Companies for their excellence, creativity, hard work and success

June 4, 2020
·
4 min read
Oncolytics Biotech® Provides Recap of Key Opinion Leader Call Highlighting the Induction of Rapid and Persistent Immune Responses With Systemic Pelareorep Treatment

Recently announced clinical data demonstrate pelareorep-induced priming of an adaptive immune response

June 4, 2020
·
9 min read
Business

Cantel Medical Reports Financial Results for its Third Quarter Fiscal Year 2020

Cantel Medical Corp. announced financial results for its third quarter ended April 30, 2020.

June 4, 2020
·
10 min read
Policy

FDA Provides 510(k) Clearance For BAUSCH + LOMB INFUSE™ Daily Disposable Silicone Hydrogel (SiHy Daily) Contact Lenses

Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc., announced that it has received 510 clearance from the U.S. Food and Drug Administration for BAUSCH + LOMB INFUSE™ daily disposable silicone hydrogel contact lenses.

June 4, 2020
·
3 min read
Biotech Bay

Protagonist Therapeutics to Present at the 25th European Hematology Association (EHA) Annual Congress

Protagonist Therapeutics, Inc. announced that the company will present data from its Phase 2 trial of PTG-300 for the treatment of beta-thalassemia at the 25th European Hematology Association Annual Congress, which will take place in a virtual format June 11-14, 2020.

June 4, 2020
·
1 min read
Business

Nevro Appoints Finance Executive Roderick MacLeod as Chief Financial Officer

Nevro Corp., a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, announced the appointment of Roderick MacLeod as Chief Financial Officer, effective June 15, 2020, with global responsibility for Finance, IT and Customer Service.

June 4, 2020
·
3 min read
Business

Immatics Appoints Cedrik Britten as Chief Medical Officer

Former Head of Oncology Cell Therapy Research Unit at GSK to lead clinical development at Immatics

June 4, 2020
·
6 min read
Genetown

Vapotherm to Expand Production Capacity in Advance of Potential Increase in Demand for High-Flow Nasal Cannula Systems for Treating COVID-19 Respiratory Distress

Vapotherm, Inc., a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI® Technology products that are used to treat patients suffering from respiratory distress, announced a major expansion in its capital equipment manufacturing capabilities.

June 4, 2020
·
9 min read